Hindustan Organic Chemicals (HOC) reported to its Board of Directors on August 7, 2026, regarding penalties imposed by the Bombay Stock Exchange (BSE) for regulatory non-compliance during the quarter ended March 31, 2026. The exchange levied fines totaling Rs. 4,92,000 plus applicable GST, citing violations of Regulation 17(1) concerning Board composition and Regulation 24A(2) regarding late submission of the Secretarial Compliance Report under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board noted that the penalty of Rs. 4,50,000 stemmed from a breach of Regulation 17(1), which mandates specific composition requirements for the Board of Directors. HOC explained that director appointments are governed by the Ministry of Chemicals & Fertilizers, Department of Chemicals & Petrochemicals, Government of India. Consequently, the company stated that the delay in meeting composition norms was beyond its control due to the statutory appointment process.

The second penalty of Rs. 42,000 was imposed for late compliance with Regulation 24A(2). The company confirmed that the Annual Secretarial Compliance Report was submitted within the prescribed timeline in both PDF and XML formats. However, an unintentional technical error caused the XML file to reflect data from the previous financial year rather than the current one. The PDF report remained accurate. The error was identified and rectified after the initial filing.

Regulatory Context and Penalties

The BSE communicated these penalties via emails dated May 27, 2026, and June 22, 2026. The exchange required the company to place these matters before its Board of Directors and disseminate the Board’s comments on the exchange portal. HOC complied by discussing the matter in its 428th Board meeting held on August 7, 2026.

Board Response and Remedial Measures

In response to the findings, the Board emphasized the need for greater caution in future filings. While the director appointment issue remains subject to government timelines, the company acknowledged internal responsibility for the technical filing error. The Board directed management to implement stricter verification protocols for electronic submissions to prevent recurrence of such discrepancies.

What the Numbers Show

The dual nature of the penalties highlights distinct risk factors for state-owned enterprises. The larger fine relates to structural governance issues tied to external administrative processes, while the smaller fine reflects operational execution errors. For investors, this underscores the dependency of HOC’s governance timeline on government bureaucracy, alongside the need for robust internal checks on regulatory filings.

Hindustan Organic Chemicals turned profitable in the first quarter of FY26, reporting a standalone net profit of ₹3.69 crore compared to a loss of ₹6.50 crore in Q1FY25. Revenue from operations declined to ₹95.99 crore from ₹163.89 crore year-on-year, driven by lower operational activity. The profit turnaround was supported by a reduction in cost of materials consumed and favorable inventory adjustments. However, the filing highlights significant corporate governance concerns, including non-compliance with SEBI listing regulations regarding board composition.

The Board of Directors approved the unaudited financial results on August 7, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory Auditors Balan & Co., Chartered Accountants, issued an unmodified opinion on both standalone and consolidated financials. The Audit Committee did not review the results due to an absence of quorum among independent directors, as required by Clause A(5) of Part C of Schedule II of the SEBI LODR Regulations.

Financial Performance

Standalone revenue from operations fell to ₹95.99 crore in Q1FY26 from ₹163.89 crore in Q1FY25. Total income decreased to ₹100.29 crore from ₹169.08 crore. Cost of materials consumed dropped significantly to ₹68.34 crore from ₹120.57 crore. A decrease in inventories contributed ₹12.76 crore to income, whereas an increase had impacted the prior year. Finance costs remained stable at ₹4.95 crore. The company reported no tax expenses due to its loss-making position in previous years and current profitability levels not triggering immediate tax liabilities.

Consolidated net profit for the period was ₹383.98 lakh, comprising ₹369.43 lakh from continuing operations and ₹14.55 lakh from discontinued operations related to its subsidiary, Hindustan Fluorocarbons Limited. Basic earnings per share for continuing operations were ₹0.55, up from a loss of ₹0.97 per share in the corresponding quarter last year.

Governance and Compliance Issues

The company disclosed material non-compliance with Regulation 17(1)(b), Regulation 17(1)(c), and Regulation 17(1E) of the SEBI LODR Regulations, 2015. The tenure of Non-Official Independent Director Vinay Kumar Sharma ended on June 4, 2026, reducing the number of independent directors to one. This resulted in a failure to meet the requirement of half the board strength being independent directors and a minimum of six directors between June 5 and June 30, 2026. Consequently, the Audit Committee and Nomination & Remuneration Committee could not meet quorum requirements under Regulation 18 and Regulation 19 of SEBI LODR and Sections 177 and 178(1) of the Companies Act, 2013. The vacancy remains unfilled, and the matter has been taken up with the Administrative Ministry.

Subsidiary and Restructuring Updates

Hindustan Fluorocarbons Limited, the subsidiary, was delisted from BSE Limited effective February 6, 2026. During FY26, Hindustan Organic Chemicals acquired an additional 2,66,741 equity shares of the subsidiary at ₹17.76 per share. The subsidiary transferred ₹1,362.03 lakh from fixed deposits to an escrow account maintained by the holding company to settle outstanding loans and interest. A Scheme of Amalgamation for the merger of the subsidiary with the holding company has been proposed by the Board, pending regulatory approvals. The holding company continues to implement a Government-approved restructuring plan, with the sale of unencumbered land at Rasayani and Panvel in progress.